yao syndrome yaos formerly called autoinflammatory autoinflammatory syndrome involving episodes fever abnormal inflammation affecting many parts body particularly skin joints gastrointestinal yao syndrome diagnosed major criteria least one minor criterion molecular criterion exclusion criteria study determine effectiveness novartis pharmaceutical drug canakinumab conducted study canakinumab effective patients yaos thus clinical trial canakinumab may warranted therapeutic option yao syndrome inheritance classified multifactorial httpsenwikipediaorgwikiyaosyndrome